These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 17931662)

  • 1. Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts.
    Lépicier P; Lagneux C; Sirois MG; Lamontagne D
    Life Sci; 2007 Oct; 81(17-18):1373-80. PubMed ID: 17931662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
    Lagneux C; Adam A; Lamontagne D
    Int Immunopharmacol; 2003 Oct; 3(10-11):1511-8. PubMed ID: 12946448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart.
    Hajrasouliha AR; Tavakoli S; Ghasemi M; Jabehdar-Maralani P; Sadeghipour H; Ebrahimi F; Dehpour AR
    Eur J Pharmacol; 2008 Jan; 579(1-3):246-52. PubMed ID: 17950273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts.
    Wagner JA; Abesser M; Harvey-White J; Ertl G
    J Cardiovasc Pharmacol; 2006 May; 47(5):650-5. PubMed ID: 16775503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis.
    Tambaro S; Casu MA; Mastinu A; Lazzari P
    Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L; Del Zar CF; Borda E
    Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CB(2) cannabinoid receptor regulates human sperm cell motility.
    Agirregoitia E; Carracedo A; Subirán N; Valdivia A; Agirregoitia N; Peralta L; Velasco G; Irazusta J
    Fertil Steril; 2010 Mar; 93(5):1378-87. PubMed ID: 19328464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
    Shearman LP; Stribling DS; Camacho RE; Rosko KM; Wang J; Tong S; Feng Y; Marsh DJ; Yu H; Guan X; Spann SK; Macneil DJ; Fong TM; Metzger JM; Goulet MT; Hagmann WK; Plummer CW; Finke PE; Mills SG; Shah SK; Truong Q; Van der Ploeg LH; Macintyre DE; Strack AM
    Eur J Pharmacol; 2008 Jan; 579(1-3):215-24. PubMed ID: 18021763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of epithelial CB1 receptors inhibits contractions of the rat prostate gland.
    Tokanovic S; Malone DT; Ventura S
    Br J Pharmacol; 2007 Jan; 150(2):227-34. PubMed ID: 17099718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imaging.
    Yao BB; Hsieh G; Daza AV; Fan Y; Grayson GK; Garrison TR; El Kouhen O; Hooker BA; Pai M; Wensink EJ; Salyers AK; Chandran P; Zhu CZ; Zhong C; Ryther K; Gallagher ME; Chin CL; Tovcimak AE; Hradil VP; Fox GB; Dart MJ; Honore P; Meyer MD
    J Pharmacol Exp Ther; 2009 Jan; 328(1):141-51. PubMed ID: 18931146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoids protect the rat isolated heart against ischaemia.
    Lépicier P; Bouchard JF; Lagneux C; Lamontagne D
    Br J Pharmacol; 2003 Jun; 139(4):805-15. PubMed ID: 12813004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH; Chen ZW; Wu Z
    Can J Physiol Pharmacol; 2008 Mar; 86(3):131-8. PubMed ID: 18418440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.
    González C; Herradón E; Abalo R; Vera G; Pérez-Nievas BG; Leza JC; Martín MI; López-Miranda V
    Diabetes Metab Res Rev; 2011 May; 27(4):331-40. PubMed ID: 21309057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
    Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
    Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia.
    Lamontagne D; Lépicier P; Lagneux C; Bouchard JF
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):242-6. PubMed ID: 16618028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide in the gastroprotective effect of ACEA, a selective cannabinoid CB1 receptor agonist, on aspirin-induced gastric ulceration.
    Rutkowska M; Fereniec-Gołebiewska L
    Pharmazie; 2009 Sep; 64(9):595-7. PubMed ID: 19827302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.
    Cianchi F; Papucci L; Schiavone N; Lulli M; Magnelli L; Vinci MC; Messerini L; Manera C; Ronconi E; Romagnani P; Donnini M; Perigli G; Trallori G; Tanganelli E; Capaccioli S; Masini E
    Clin Cancer Res; 2008 Dec; 14(23):7691-700. PubMed ID: 19047095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors.
    Sagredo O; Ramos JA; Decio A; Mechoulam R; Fernández-Ruiz J
    Eur J Neurosci; 2007 Aug; 26(4):843-51. PubMed ID: 17672854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.
    Maslov LN; Khaliulin I; Zhang Y; Krylatov AV; Naryzhnaya NV; Mechoulam R; De Petrocellis L; Downey JM
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):262-72. PubMed ID: 26487546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.